InvestorsHub Logo
icon url

TheBunny

05/31/18 12:10 PM

#229631 RE: DaubersUP #229624

To my understanding, IPIX needs completed Phase 3 Positive tests to demonstrate that they have 'Save and effective drugs'. Until then then, IPIX has formulations that may show promise.

Plus, IPIX is rapidly running out of funds to continue further testing on their own, hence the desperate .25 funding from Aspire for 8M shares to only get $2M in cash.

20 CDA's only show that there are companies that want to have a look at what IPIX really has proven to date, not that they will be involved in some 'Bidding War' with other BP's.

Share Price also indicates that there is no insider buying, as the chart indicates SP is trending into the .30's.

All combined, it's not looking good currently for IPIX. Leo's silence on key issues of concern, indicates (to me), that there are more problems with the company than we know.


IPIX have safe and effective drugs. 8 human mid stage trials prove that. 20 plus CDAs prove there is major interest.

icon url

BooDog

05/31/18 1:31 PM

#229638 RE: DaubersUP #229624

$IPIX meets all endpoints. All trials to date pending prurisol data. Some may need to review the protocols and see the benefits to patients already.

And some just don't have the stomach for biotech. The lack of patience by some is clear.

Looking forward to the next steps here. They won't be little ones imo.

Message in reply to:

Because there is competition. IPIX have safe and effective drugs. 8 human mid stage trials prove that. 20 plus CDAs prove there is major interest. BP needs to refill pipelines to keep shareholders happy.

B-OM will be the leader in an untapped market. You better believe someone will jump ahead the next to gain 500 million plus a year into the billions potentially.

Real world bun. Money is required